𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation

✍ Scribed by A. A. Khan; Judith G. Villablanca; C. Patrick Reynolds; Vassilios I. Avramis


Publisher
Springer
Year
1996
Tongue
English
Weight
344 KB
Volume
39
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


13-cis-retinoic acid (NSC 122758) in the
✍ Finklestein, Jerry Z. ;Krailo, Mark D. ;Lenarsky, Carl ;Ladisch, Stephen ;Blair, πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 428 KB

## Abstract The Childrens Cancer Study Group evaluated daily oral 13‐cis‐retinoic acid to determine its therapeutic efficacy in 28 children with advanced neuroblastoma refractory to conventional therapy. Cheilitis and fissured lips were the most common side effects; however, fewer than 50% of the p

13-cis-retinoic acid in the treatment of
✍ Zachary B. Kramer; Laszlo Boros; Peter H. Wiernik; Janet Andersen; John M. Benne πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 297 KB πŸ‘ 2 views

The management of acute myeloid leukemia in the elderly (65 years and older) is unsatisfactory because of poor patient tolerance of standard myeloablative chemotherapy. The authors conducted a Phase II study to evaluate the effectiveness and toxicity of 13-cis-retinoic acid (CRA) in the therapy of e

Analysis of factors related to the occur
✍ Sabah Sallah; Jim Y. Wan; Nam P. Nguyen; Paul Vos; George Sigounas πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 3 views

BACKGROUND. Chronic disseminated candidiasis (CDC) is a serious complication of treatment in patients with acute leukemia. Although some general risk factors are known to predispose to systemic fungal infections, few studies have addressed the relevance of certain clinical and laboratory features in

Interferon-Ξ±-2a with or without 13-cis r
✍ Sophie D. FossΓ₯; Gerald H. J. Mickisch; Pieter H. M. De Mulder; Simon Horenblas; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 130 KB

## Background: In patients with metastatic renal cell carcinoma (mrcc), interferon-alpha (ifn) monotherapy leads to response rates of 5-15%, dependent on the selection of patients. in 1995, preclinical and clinical data indicated an improvement of these results if ifn was combined with 13-cis retin